AT384795T
Modified hiv env polypeptides
Abstract
A polynucleotide encoding an HIV Env polypeptide modified in the polypeptide has at least one removed amino acid or replaced as compared to wild type of the region corresponding to residues 420-436 numbered relative to HXB-2 (SEQ ID NO : 1).
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
143 members in 13 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 11449598 | United States of America | P | |
| 15667099 | United States of America | P |
Members143
| Document | Office | Kind | |
|---|---|---|---|
| CA2358385A1 | Canada | A1 | |
| CA2358915A1 | Canada | A1 | |
| CA2360347A1 | Canada | A1 | |
| WO0039302A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0039303A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0039304A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2221600A | Australia | A | |
| AU2487300A | Australia | A | |
| AU2596600A | Australia | A | |
| WO0039303A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0039304A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO0039302A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0039304A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1141313A2 | European Patent Office (EPO) | A2 | |
| EP1141314A2 | European Patent Office (EPO) | A2 | |
| EP1141315A2 | European Patent Office (EPO) | A2 | |
| CA2414374A1 | Canada | A1 | |
| WO0204493A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7317901A | Australia | A | |
| ZA200105590B | South Africa | B | |
| ZA200105589B | South Africa | B | |
| JP2002533124A | Japan | A | |
| JP2002533125A | Japan | A | |
| US2002146683A1 | United States of America | A1 | |
| CA2452015A1 | Canada | A1 | |
| CA2452119A1 | Canada | A1 | |
| CA2634992A1 | Canada | A1 | |
| CA2785699A1 | Canada | A1 | |
| WO03004620A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03004657A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2002320314A1 | Australia | A1 | |
| CA2458995A1 | Canada | A1 | |
| WO03020876A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002316578A1 | Australia | A1 | |
| CA2453228A1 | Canada | A1 | |
| WO03027022A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002356505A1 | Australia | A1 | |
| WO0204493A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003143248A1 | United States of America | A1 | |
| US6602705B1 | United States of America | B1 | |
| WO03027022A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2003523721A | Japan | A | |
| EP1339738A2 | European Patent Office (EPO) | A2 | |
| US2003170614A1 | United States of America | A1 | |
| US2003194800A1 | United States of America | A1 | |
| US2003198621A1 | United States of America | A1 | |
| US2003223961A1 | United States of America | A1 | |
| US2003223964A1 | United States of America | A1 | |
| WO03020876A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO03004620A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2004502445A | Japan | A | |
| US6689879B2 | United States of America | B2 | |
| EP1409694A1 | European Patent Office (EPO) | A1 | |
| EP1411770A2 | European Patent Office (EPO) | A2 | |
| EP1427806A2 | European Patent Office (EPO) | A2 | |
| EP1433851A2 | European Patent Office (EPO) | A2 | |
| ZA200300839B | South Africa | B | |
| EP1433851A3 | European Patent Office (EPO) | A3 | |
| JP2004537303A | Japan | A | |
| ZA200403143B | South Africa | B | |
| US6893567B1 | United States of America | B1 | |
| EP1535995A1 | European Patent Office (EPO) | A1 | |
| JP2005521380A | Japan | A | |
| ZA200400802B | South Africa | B | |
| JP2005523679A | Japan | A | |
| US2005214256A1 | United States of America | A1 | |
| ZA200402513B | South Africa | B | |
| EP1409694A4 | European Patent Office (EPO) | A4 | |
| ZA200400793B | South Africa | B | |
| US2006057115A1 | United States of America | A1 | |
| EP1427806A4 | European Patent Office (EPO) | A4 | |
| EP1411770A4 | European Patent Office (EPO) | A4 | |
| US7211659B2 | United States of America | B2 | |
| US7282364B2 | United States of America | B2 | |
| EP1141315B1 | European Patent Office (EPO) | B1 | |
| AT384795TThis record | Austria | T | |
| DE69938062D1 | Germany | D1 | |
| US7348177B2 | United States of America | B2 | |
| US2008089908A1 | United States of America | A1 | |
| US2008095833A1 | United States of America | A1 | |
| PT1141315E | Portugal | E | |
| ES2299276T3 | Spain | T3 | |
| DK1141315T3 | Denmark | T3 | |
| EP1980617A1 | European Patent Office (EPO) | A1 | |
| US2008261271A1 | United States of America | A1 | |
| US2009004733A1 | United States of America | A1 | |
| DE69938062T2 | Germany | T2 | |
| US2009047339A1 | United States of America | A1 | |
| JP2009039116A | Japan | A | |
| JP2009082136A | Japan | A | |
| JP4302513B2 | Japan | B2 | |
| JP2009254383A | Japan | A | |
| US7618642B2 | United States of America | B2 | |
| US2009304740A1 | United States of America | A1 | |
| US7662916B2 | United States of America | B2 | |
| US2010092502A1 | United States of America | A1 | |
| US7718401B2 | United States of America | B2 | |
| CA2358915C | Canada | C | |
| EP2206785A1 | European Patent Office (EPO) | A1 | |
| EP1339738B1 | European Patent Office (EPO) | B1 |
Showing 100 of 143
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99968574
Titles2
- German
- MODIFIZIERTE HIV ENV POLYPEPTIDE
- English
- MODIFIED HIV ENV POLYPEPTIDE
Classification
- CPC, 18
- C12N7/00
- A61K39/00
- A61K48/00
- A61K2039/5156
- A61K2039/5256
- A61K2039/5258
- A61K2039/53
- A61K2039/54
- A61P31/18
- C07K14/005
- A61P37/02
- C12N2740/16023
- C12N2740/16052
- C12N2740/16062
- C12N2740/16122
- C12N2740/16222
- C12N2740/16322
- C12N2770/24222
- IPC, 13
- A61K39 00
- A61K39 12
- A61K39 42
- A61K48 00
- A61P31 18
- A61P37 02
- C07K14 155
- C07K14 16
- C07K14 18
- C12N15 09
- C12N15 49
- C12N15 867
- C12N7 04